Reuters
25 Sept 2026, 07:58 UTC · 1h ago
Verdict
Headline leans bullish. We score NANX +1.00 across one claim.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+1.00strongly bullish
What the story claims
1 claim · scored −1 bearish … +1 bullish · 1 new · 0 priced in
Nanexa signed a global licensing deal with Novo Nordisk worth up to €1.17 billion.
Newshares soar in early Friday trading
More positive than 99% of claims this week
Which stocks this story touches
Continue reading
5 related stories
More positive than 99% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 99% of ticker scores this week
Shares more than doubled following a global licensing deal worth up to €1.17 billion.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
3h ago
—
No price for NANX right now — the quote feed didn't answer.
NANX chart →
